Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al

Ann Rheum Dis. 2021 Jun;80(6):e88. doi: 10.1136/annrheumdis-2020-218328. Epub 2020 Jun 30.

Milena Gianfrancesco¹, Kimme L Hyrich², Jinoos Yazdany³, Pedro M Machado^{4

5}, Philip C Robinson^{6

7}

¹ Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, California, USA.
² Centre for epidemiology Versus arthritis, University of Manchester, Manchester, UK.
³ Medicine/Rheumatology, University of California, San Francisco, California, USA.
⁴ MRC Centre for Neuromuscular Diseases, University College London, London, UK.
⁵ Rheumatology, University College London Centre for Rheumatology, London, UK.
⁶ Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia philip.robinson@uq.edu.au.
⁷ Metro North Hospital & Health Service, Royal Brisbane and Woman's Hospital Health Service District, Herston, Queensland, Australia.

No abstract available

Keywords: arthritis, rheumatoid; lupus erythematosus, systemic; spondylitis, ankylosing.

Publication types